How should a 1 g dose of ferric carboxymaltose be diluted for intravenous infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

FCM 1g Dilution Protocol

Dilute ferric carboxymaltose 1000 mg in 100 mL of normal saline (0.9% NaCl) and infuse over 20-30 minutes 1.

Preparation Details

The dilution protocol is straightforward and consistent across expert guidelines:

  • Volume: 100 mL normal saline
  • Infusion time: 20-30 minutes
  • Container: Can use polypropylene bottles or bags (both demonstrate stability for up to 72 hours at 30°C) 2

Administration Technique

Start the infusion slowly and observe for several minutes before completing the infusion over the remaining time 1. This initial slow start allows for early detection of any infusion reactions, which occur in approximately 1-3% of patients.

Key Safety Precautions

  • Monitor for acute onset of minor infusion reactions throughout administration
  • Check blood pressure after infusion (hypertension with facial flushing can occur)
  • Have standard infusion reaction management protocols readily available

Important U.S. Dosing Context

In the United States, FCM is distributed exclusively as 750 mg vials. To achieve a 1000 mg dose, you must use two vials (1500 mg total), resulting in 500 mg wastage, or accept the 750 mg dose 1. This is a significant practical limitation compared to Europe and Asia where 1000 mg single-dose vials are standard.

Alternatively, the 1000 mg/20 mL single-dose vial formulation exists 3, which would eliminate wastage if available at your institution.

Clinical Considerations

Avoid FCM in patients requiring repeat infusions due to treatment-emergent hypophosphatemia risk 1. This is a critical safety consideration that distinguishes FCM from other IV iron formulations like ferric derisomaltose.

Stability Data

If preparation occurs in advance, the diluted solution maintains physicochemical stability for up to 72 hours when stored at 30°C in polypropylene containers 2. However, standard practice uses immediate administration after preparation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.